Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.


 
Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:

Subscribe

Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

...41424344454647484950...
CompanyDrug NameStatusIndication Group
Unigene Laboratories FORTICAL Approved in USAMusculoskeletal system
Watson Fortamet Approved in USAAlimentary tract & metabolism
SkyePharma Formoterol-Combi in Phase IIRespiratory system
Unigene Laboratories Forcaltonin Approved in EUMusculoskeletal system
Novartis Foradil Approved in Germany, submitted in USARespiratory system
Endocyte FolateImmune accomplished Phase IAntineoplastic & immunomodulating agents
Biocryst Fodosine in Phase IIAntineoplastic & immunomodulating agents
Celgene Focalin XR Approved in USANervous system
Novartis Focalin XR Approved in USANervous system
UCB Pharma Fluxid Approved in USAAlimentary tract & metabolism
GlaxoSmithKline Fluviral, in Phase IAnti-infectives for systemic use
Shire FLUVIRAL accomplished Phase IIAnti-infectives for systemic use
Myriad Genetics Flurizan accomplished Phase IIAntineoplastic & immunomodulating agents
Myriad Genetics Flurizan in Phase IIINervous system
MedImmune FluMist Approved in USAAnti-infectives for systemic use
GlaxoSmithKline FluINsure accomplished Phase IIAnti-infectives for systemic use
Bayer Fludara Approved in JapanAntineoplastic & immunomodulating agents
Protein Sciences FluBlok in Phase IIIAnti-infectives for systemic use
GlaxoSmithKline Fluarix Approved in USAAnti-infectives for systemic use
GlaxoSmithKline Flovent HFA Approved in USARespiratory system
...41424344454647484950...




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.